FDA Commissioner Marty Makary called these changes “common-sense reforms” that could expedite the development of cell and ...

Sugar Land has authorized an $1 million incentive for stem cell therapy company Hope Biosciences as city leaders look to ...

"Regulatory flexibility must be tailored for cell and gene therapies," commented FDA Commissioner Marty Makary. "These are ...

Pluri (PLUR), an established global leader in the development and manufacturing of cell-based therapeutics, launches new revenue-generating Contract Development and Manufacturing Organization (CDMO) ...

We spoke with Scott Jones, PhD, SVP & CSO at BioBridge Global (BBG) to understand the challenges of product-specific potency ...

The cell and gene therapy sector has never lacked attention, but all too often, the narrative swings from one extreme to ...

CGTxchange leverages the combined capabilities of the organizations in an unprecedented way to engage a broad array of potential partners and funders to efficiently identify, evaluate, finance, ...

In this free webinar, explore approaches to developing and implementing proliferation, AAV/mRNA potency, cell killing and flow cytometry assays in cell therapy development. Attendees will learn how ...

Next-generation automation is closing the gap between curative science and real-world demand, enabling faster development, ...

PRINCETON, N.J., March 17, 2025 /PRNewswire/ -- BioCentriq, a leading cell therapy contract development and manufacturing organization (CDMO), today announced a company rebrand and its new launch as ...

AGC Biologics, your friendly CDMO expert, will commence cell therapy process development and clinical manufacturing services on July 1, 2025, at AGC Inc.’s Yokohama Technical Center, marking the ...

With iPSCs continuing to emerge as an important source of starting materials for cell therapy developers, it is crucial to tackle key remaining challenges relating to cell culture scalability and ...